Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Clinical trial NCT02369926 · UNKNOWN

Trial details

NCT number: NCT02369926
Sponsor: Transparency Life Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2014-11-01
Primary completion: 2018-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.